One of the heterogeneous BC subtypes is triple-negative breast cancer (TNBC), which lacks three molecular targets: estrogen receptor (ER), human epidermal growth factor receptor-2 (HER-2), and progesterone receptor (PR) 9. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.